» Articles » PMID: 31646768

Current Status of Atrial Fibrillation Ablation with Balloon Strategy

Overview
Journal Korean Circ J
Date 2019 Oct 25
PMID 31646768
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Catheter ablation of atrial fibrillation (AF) has been established worldwide and is recommended for symptomatic paroxysmal AF patients according to international guidelines. Importantly, the cornerstone of any AF ablation represents pulmonary vein isolation (PVI). Traditional radiofrequency (RF) point by point ablation within a 3D electroanatomic left atrial (LA) map requires profound understanding of LA anatomy and electrophysiology. This ablation strategy can be highly efficient and safe if performed in experienced hands and centers. However, procedural complexity causes a long learning curve and has limited its wide spread utilization. In contrast, balloon based PVI ablation strategies are based on an anatomic principle. Currently, two balloon types (cryoballoon and laserballoon) have been adopted to clinical routine. Both balloons are positioned at the target PV and circumferential energy ablation is enabled. This simplified anatomic approach facilitates reaching the procedural endpoint of PVI and demonstrated less operator dependency. Therefore, balloon PVI appears to be associated with improved procedural reproducibility and safety. Importantly, large scale randomized trials proved non-inferiority of balloon guided AF ablation (cryothermal and laser energy) vs. experienced operators using traditional "gold standard" RF ablation in paroxysmal and persistent AF. Ongoing technological refinements of both balloons as well as the introduction of novel energy dosing strategies and ablation targets may potentially impact the current way of ablating AF in future. This review will summarize current clinical experience of contemporary balloon devices and will look into future developments.

Citing Articles

Cryoballoon vs. laser balloon ablation for atrial fibrillation: a meta-analysis.

Sun X, Zhao S, Yu S, Cui K Front Cardiovasc Med. 2024; 10:1278635.

PMID: 38169911 PMC: 10761002. DOI: 10.3389/fcvm.2023.1278635.


Acute and long-term results with the 3 generation visually guided laser balloon ablation system for pv isolation.

Funasako M, Petru J, Hala P, Janotka M, Skoda J, Chovanec M J Interv Card Electrophysiol. 2023; 67(1):53-60.

PMID: 36805921 PMC: 10770210. DOI: 10.1007/s10840-023-01499-8.


X-ray exposure in cryoballoon versus radiofrequency ablation for atrial fibrillation over 7 years: A single center study.

Heinroth K, Blum T, Drexler M, Plehn A, Hartkopf T, Horenburg C J Arrhythm. 2022; 38(6):1017-1027.

PMID: 36524039 PMC: 9745457. DOI: 10.1002/joa3.12780.

References
1.
Bordignon S, Chen S, Perrotta L, Bologna F, Nagase T, Konstantinou A . Durability of cryoballoon left atrial appendage isolation: Acute and invasive remapping electrophysiological findings. Pacing Clin Electrophysiol. 2019; 42(6):646-654. DOI: 10.1111/pace.13690. View

2.
Kuniss M, Greiss H, Pajitnev D, Akkaya E, Deubner N, Hain A . Cryoballoon ablation of persistent atrial fibrillation: feasibility and safety of left atrial roof ablation with generation of conduction block in addition to antral pulmonary vein isolation. Europace. 2016; 19(7):1109-1115. DOI: 10.1093/europace/euw146. View

3.
Dukkipati S, Cuoco F, Kutinsky I, Aryana A, Bahnson T, Lakkireddy D . Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation. J Am Coll Cardiol. 2015; 66(12):1350-60. DOI: 10.1016/j.jacc.2015.07.036. View

4.
Metzner A, Reissmann B, Rausch P, Mathew S, Wohlmuth P, Tilz R . One-year clinical outcome after pulmonary vein isolation using the second-generation 28-mm cryoballoon. Circ Arrhythm Electrophysiol. 2014; 7(2):288-92. DOI: 10.1161/CIRCEP.114.001473. View

5.
Reddy V, Sediva L, Petru J, Skoda J, Chovanec M, Chitovova Z . Durability of Pulmonary Vein Isolation with Cryoballoon Ablation: Results from the Sustained PV Isolation with Arctic Front Advance (SUPIR) Study. J Cardiovasc Electrophysiol. 2015; 26(5):493-500. DOI: 10.1111/jce.12626. View